Carol R. Lizak, CFO of Jaguar Health, Inc. ($JAGX), made one open market purchase of shares in the last year, totaling $0 on March 31, 2025. This ranks her 4,947th among 4,983 insiders by purchase amount, below the average of $1.46 million across 3.3 transactions. She reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | A | Stock Option (right to buy) | 11740 | $0.00 | 11,740.0000 | 3,735,837 | 9999.99% | 0.31% |
| Dec. 11, 2025 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | A | Common Stock | 11740 | $0.00 | 11,911.0000 | 3,735,837 | 6865.50% | 0.31% |
| March 31, 2025 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | P | Convertible Promissory Note | 5400 | $30000.00 | 5,400.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | P | Warrant to Purchase Common Stock | 5400 | $0.00 | 5,400.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | A | Common Stock | 4280 | $0.00 | 4,298.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | A | Stock option (right to buy) | 34240 | $0.00 | 34,240.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2024 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 431 | $0.00 | 1,148.0000 | 0 | 60.11% | 0.00% |
| May 17, 2024 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | M | Restricted stock units | 431 | $0.00 | 431.0000 | 0 | 50.00% | 0.00% |
| April 5, 2024 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | A | Restricted stock units | 60 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 5, 2024 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 60 | $0.00 | 717.0000 | 0 | 9.13% | 0.00% |
| Aug. 14, 2023 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | A | Common Stock | 142088 | $0.00 | 150,713.0000 | 0 | 1647.40% | 0.00% |
| May 17, 2023 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | M | Restricted stock units | 431 | $0.00 | 862.0000 | 0 | 33.33% | 0.00% |
| May 17, 2023 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 431 | $0.00 | 8,625.0000 | 0 | 5.26% | 0.00% |
| April 5, 2023 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 60 | $0.00 | 226.0000 | 0 | 36.14% | 0.00% |
| April 5, 2023 | Jaguar Health, Inc. | $JAGX | Lizak Carol R. | Chief Financial Officer | A | Restricted stock units | 60 | $0.00 | 60.0000 | 0 | 9999.99% | 0.00% |